✦ LIBER ✦

Irreversibility of the interaction of human growth hormone with its receptor and analysis of irreversible reactions in radioreceptor assays—Theoretical considerations

✍ Scribed by G. S. Murthy; H. G. Friesen

Book ID: 112829169
Publisher: Indian Academy of Sciences
Year: 1985
Tongue: English
Weight: 431 KB
Volume: 7
Category: Article
ISSN: 0250-5991
DOI: 10.1007/bf02703581

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Practical considerations in analyzing ra

Practical considerations in analyzing radioreceptor assays by Scatchard analysis and capacity determination in irreversible hormone receptor interactions

✍ G. S. Murthy; H. G. Friesen 📂 Article 📅 1985 🏛 Indian Academy of Sciences 🌐 English ⚖ 429 KB

Identification and functional analysis o

Identification and functional analysis of novel human growth hormone–releasing hormone receptor (GHRHR) gene mutations in Japanese subjects with short stature

✍ Hiroshi Inoue; Natsumi Kangawa; Atsuko Kinouchi; Yukiko Sakamoto; Chizuko Kimura 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

P-195 Expression of growth hormone and o

P-195 Expression of growth hormone and of its receptor in human endometrium during the menstrual cycle and in ectopic endometrium of women with endometriosis

✍ M Sbracia; F Scarpellini; S Biamonti; A Fanfani; R Boccadoro; R Poverini; S Mona 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Kinetic characterization of the interact

Kinetic characterization of the interaction of biotinylated human interleukin 5 with an Fc chimera of its receptor α subunit and development of an ELISA screening assay using real-time interaction biosensor analysis

✍ Donald Bennett; Thomas Morton; Ann Breen; Robert Hertzberg; Donna Cusimano; Edwa 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 736 KB

## Abstract The interaction of biotinylated human interleukin 5 ([BT]hIL5) with immobilized receptor was measured with a real‐time biosensor, and these results were used as a basis for configuring as ELSIA for screening antagonists of hIL5‐receptor binding. The recombinant proteins used, hIL5 and s